Who is sponsoring NCT05409742?

NCT05409742 is sponsored by Cairo University.

What drugs are being tested in NCT05409742?

Interventions in NCT05409742: Modified Hall technique.

What condition does NCT05409742 study?

NCT05409742 studies Masseter Muscle Activity.

Is NCT05409742 still recruiting?

NCT05409742 is currently status unknown. Last updated 8 June 2022.

Last reviewed 2022-06-08 · How we verify

NCT05409742

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Masseter Muscle Activity and Post-operative Pain in a Group of Egyptian Children Treated With Hall Technique Vs Modified Hall Technique

Status unknown NA Last updated 8 June 2022

What this trial tests

NA trial testing Modified Hall technique in Masseter Muscle Activity in 30 participants. Status unknown.

Timeline

1 October 2022

Primary endpoint
31 December 2022

1 September 2023

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	30
Start date	1 October 2022
Primary completion	31 December 2022
Estimated completion	1 September 2023
Sites	1 location across Egypt

Drugs / interventions tested

Modified Hall technique

Conditions studied

Masseter Muscle Activity — all drugs for Masseter Muscle Activity →

Sponsor

Cairo University

Who can join

Adults 5 to 7, any sex, with Masseter Muscle Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to evaluate postoperative pain and masseter muscle activity in a group of Egyptian children with carious primary molars treated with Hall Vs modified Hall Technique (with proximal and occlusal reduction).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05409742 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 8 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05409742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing